National Conference of the Italian Group for the Study of Neuromorphology
Vol. 70 No. s2 (2026): 36th National Conference of the Italian Group for the Study of...

P026 | FROM PERIPHERAL INFLAMMATION TO NEUROINFLAMMATION: INVESTIGATING BLOOD-BRAIN BARRIER DYSFUNCTION IN AN ORGAN-ON-CHIP MODEL

T.K. De Angelis1|2, L. La Barbera1|2, I. Ferrari1|2, S. Giannitelli1, M. D'Amelio1|2 | 1Department of Medicine and Surgery, Laboratory of Molecular Neuroscience, Campus Bio-Medico University of Roma, Italy; 2Department of Experimental Neurosciences, LIFE - Istituto Ricerca e Cura - Santa Lucia IRCCS, Rome, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
0
Views
0
Downloads

Authors

Alzheimer's disease (AD) is increasingly recognized not only as a brain-centered pathology but also as a systemic condition in which peripheral inflammation contributes to disease onset and progression. Pro-inflammatory mediators such as IL-1β, IL-6 and TNF-α, together with soluble TNF receptors, are elevated in the plasma of AD patients, and elevated peripheral inflammatory markers predict the conversion to mild cognitive impairment or AD dementia in healthy individuals. The blood-brain barrier (BBB), a specialized endothelial interface that separates the systemic circulation from the brain, represents the first target of these circulating factors; its disruption may allow inflammatory molecules to enter the central nervous system, sustaining microglia-driven neuroinflammation and, ultimately, neuronal dysfunction. How chronic peripheral inflammation trigger BBB damage and propagates to central immune responses, however, is still poorly defined. To address this question, we developed a custom-made BBB-on-chip model. Fabricated in PDMS by replica molding, the device consists of two overlapping chambers separated by a thin, porous membrane, culturing brain microvascular endothelial cells in the “vascular” channel, and microglial cells in the lower “parenchymal” chamber. Barrier integrity was validated by transendothelial electrical resistance (TEER) measurements, immunofluorescence for tight (ZO-1) and adherens (VE-cadherin) junctions, and Lucifer Yellow permeability assay. Exposure of the vascular side to an AD-like pro-inflammatory cytokine cocktail (IL-1β, IL-6, TNF-α) induced a progressive, time-dependent breakdown of junctional architecture, a significant drop in TEER values, increased barrier permeability, elevated MMP9 levels, and reduced cell survival. Crucially, blood-side inflammation simultaneously induced marked morphological alterations in the parenchymal microglia, indicative of reactive microglial activation. Overall, these findings show that peripheral inflammatory molecules directly compromise BBB integrity and actively drive central neuroinflammation, establishing this BBB-on-chip platform as a robust tool to dissect the peripheral-to-central inflammation axis in AD.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
P026 | FROM PERIPHERAL INFLAMMATION TO NEUROINFLAMMATION: INVESTIGATING BLOOD-BRAIN BARRIER DYSFUNCTION IN AN ORGAN-ON-CHIP MODEL: T.K. De Angelis1|2, L. La Barbera1|2, I. Ferrari1|2, S. Giannitelli1, M. D’Amelio1|2 | 1Department of Medicine and Surgery, Laboratory of Molecular Neuroscience, Campus Bio-Medico University of Roma, Italy; 2Department of Experimental Neurosciences, LIFE - Istituto Ricerca e Cura - Santa Lucia IRCCS, Rome, Italy. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 20];70(s2). Available from: https://www.ejh.it/ejh/article/view/4846